University Retina and macula Associates, PC
Oak Forest, Illinois, United States
Ophthalmologist in Oak Forest, Illinois
6320 W 159th St suite a, Oak Forest, IL 60452
About University Retina and macula Associates, PC
"About University Retina University Retina is a full-service practice that specializes in helping patients heal eyesight-robbing diseases of the retina, vitreous, and macula. Led by a team of board-certified ophthalmologists and retina specialists, the practice has locations in Oak Forest, Bedford Park, Lemont, and Downers Grove, Illinois. With a dedication to education, technology, charity, and compassionate care, the University Retina team strives to provide patients with the highest level of retinal care in the world. The physicians diagnose and treat retinal-related conditions, including macular degeneration, diabetic retinopathy, retinal detachment repair, and other disorders of the retina, vitreous, and macula."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Genentech, Inc.
3
Oxurion
2
REGENXBIO Inc.
1
Clinical Trials at University Retina and macula Associates, PC
During the past decade, University Retina and macula Associates, PC conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on
average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-09-18
2018-01-29
Terminated
906
A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
2016-04-27
2017-12-14
Completed
229
A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy
2020-06-05
2023-07-18
Active, not recruiting
104
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
2020-07-31
2023-12-01
Recruiting
126
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) Without Center Involved-Diabetic Macular Edema (CI-DME)
2020-11-20
2024-10-01
Recruiting
100
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
2020-12-08
2023-01-04
Completed
37
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
2021-03-02
2023-06-15
Active, not recruiting
553
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
2021-03-02
2023-07-13
Active, not recruiting
729
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University Retina and macula Associates, PC"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at University Retina and macula Associates, PC
According to Clinical.Site data, the most researched conditions in "University Retina and macula Associates, PC" are
"Diabetic Macular Edema" (4 trials), "Diabetic Retinopathy" (3 trials), "Diabetes Mellitus" (2 trials), "Geographic Atrophy" (2 trials) and "Macular Edema" (2 trials). Many other conditions were trialed in "University Retina and macula Associates, PC" in a lesser frequency.
Clinical Trials Intervention Types at University Retina and macula Associates, PC
Most popular intervention types in "University Retina and macula Associates, PC" are "Drug" (11 trials), "Other" (2 trials), "Procedure" (2 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (4 trials), "Aflibercept" (3 trials), "Sham Procedure" (2 trials), "Aflibercept 2mg" (1 trials) and "LUCENTIS (ranibizumab injection)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University Retina and macula Associates, PC
The vast majority of trials in "University Retina and macula Associates, PC" are
12 trials for "All" genders.
Clinical Trials Status at University Retina and macula Associates, PC
Currently, there are NaN active trials in "University Retina and macula Associates, PC".
undefined are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University Retina and macula Associates, PC,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University Retina and macula Associates, PC, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".